Showing results (71-80 of 97) with videos related to

Sort By:
Pageof 10
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2018
PTEN Expression, Not Mutation Status in TSC1, TSC2, or mTOR, Correlates with the Outcome on Everolimus in Patients with Renal Cell Carcinoma Treated on the Randomized RECORD-3 TrialMartin H Voss, David Chen, Albert Reising, et al.
The Journal of Infectious Diseases|July 25, 2024
Efficacy, Safety, and Pharmacokinetics by Body Mass Index Category in Phase 3/3b Long-Acting Cabotegravir Plus Rilpivirine TrialsEmilie R Elliot, Joseph W Polli, Parul Patel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2023
A First-in-Human Phase I Study of Milademetan, an MDM2 Inhibitor, in Patients With Advanced Liposarcoma, Solid Tumors, or LymphomasMrinal M Gounder, Todd M Bauer, Gary K Schwartz, et al.
British Journal of Clinical Pharmacology|June 13, 2022
Population pharmacokinetics of cabotegravir following administration of oral tablet and long-acting intramuscular injection in adult HIV-1-infected and uninfected subjectsKelong Han, Mark Baker, Mark Lovern, et al.
HIV Medicine|December 26, 2023
Asian participants' experience in phase 3/3b studies of long-acting cabotegravir and rilpivirine: Efficacy, safety, pharmacokinetic, and virological outcomes through week 96Shinichi Oka, Vicki Holohan, Takuma Shirasaka, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 27, 2013
Disposition and metabolism of GSK2251052 in humans: a novel boron-containing antibioticGary D Bowers, David Tenero, Parul Patel, et al.
HIV Medicine|November 22, 2022
Pregnancy outcomes and pharmacokinetics in pregnant women living with HIV exposed to long-acting cabotegravir and rilpivirine in clinical trialsParul Patel, Susan L Ford, Mark Baker, et al.
The Lancet. Oncology|December 25, 2019
Transcriptomic signatures related to the obesity paradox in patients with clear cell renal cell carcinoma: a cohort studyAlejandro Sanchez, Helena Furberg, Fengshen Kuo, et al.
Cancer Discovery|January 10, 2019
Transcriptomic Profiling of the Tumor Microenvironment Reveals Distinct Subgroups of Clear Cell Renal Cell Cancer: Data from a Randomized Phase III TrialA Ari Hakimi, Martin H Voss, Fengshen Kuo, et al.
Open Forum Infectious Diseases|June 17, 2024
Cabotegravir + Rilpivirine Long-Acting: Overview of Injection Guidance, Injection Site Reactions, and Best Practices for Intramuscular Injection AdministrationPaula Teichner, Nadine Chamay, Emilie Elliot, et al.
Pageof 10